These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11193892)
1. New analogues of camptothecins. Activity and resistance. Boven E; Van Hattum AH; Hoogsteen I; Schlüper HM; Pinedo HM Ann N Y Acad Sci; 2000; 922():175-7. PubMed ID: 11193892 [No Abstract] [Full Text] [Related]
2. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts. Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606 [TBL] [Abstract][Full Text] [Related]
3. Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin. De Cesare M; Pratesi G; Perego P; Carenini N; Tinelli S; Merlini L; Penco S; Pisano C; Bucci F; Vesci L; Pace S; Capocasa F; Carminati P; Zunino F Cancer Res; 2001 Oct; 61(19):7189-95. PubMed ID: 11585754 [TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect of camptothecin analog on liver metastatic model of human colon cancer in nude mice]. Takiguchi S; Shimazoe T; Kono A Gan To Kagaku Ryoho; 1994 Apr; 21(5):705-8. PubMed ID: 8154898 [No Abstract] [Full Text] [Related]
5. Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization. Rose WC; Marathe PH; Jang GR; Monticello TM; Balasubramanian BN; Long B; Fairchild CR; Wall ME; Wani MC Cancer Chemother Pharmacol; 2006 Jul; 58(1):73-85. PubMed ID: 16228206 [TBL] [Abstract][Full Text] [Related]
6. The dual topoisomerase inhibitor, BN 80927, is highly potent against cell proliferation and tumor growth. Huchet M; Demarquay D; Coulomb H; Kasprzyk P; Carlson M; Lauer J; Lavergne O; Bigg D Ann N Y Acad Sci; 2000; 922():303-5. PubMed ID: 11193907 [No Abstract] [Full Text] [Related]
7. Structure-activity relationship of alkyl camptothecin esters. Cao Z; Pantazis P; Mendoza J; Early J; Kozielski A; Harris N; Vardeman D; Liehr J; Stehlin JS; Giovanella B Ann N Y Acad Sci; 2000; 922():122-35. PubMed ID: 11193888 [TBL] [Abstract][Full Text] [Related]
8. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of resistance to camptothecins. Saleem A; Edwards TK; Rasheed Z; Rubin EH Ann N Y Acad Sci; 2000; 922():46-55. PubMed ID: 11193924 [TBL] [Abstract][Full Text] [Related]
10. The activity profile of the hexacyclic camptothecin derivative DX-8951f in experimental human colon cancer and ovarian cancer. van Hattum AH; Pinedo HM; Schlüper HM; Erkelens CA; Tohgo A; Boven E Biochem Pharmacol; 2002 Oct; 64(8):1267-77. PubMed ID: 12234607 [TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice. Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608 [TBL] [Abstract][Full Text] [Related]
12. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues. Emerson DL; Besterman JM; Brown HR; Evans MG; Leitner PP; Luzzio MJ; Shaffer JE; Sternbach DD; Uehling D; Vuong A Cancer Res; 1995 Feb; 55(3):603-9. PubMed ID: 7834631 [TBL] [Abstract][Full Text] [Related]
13. Novel camptothecin derivative BNP1350 in experimental human ovarian cancer: determination of efficacy and possible mechanisms of resistance. Van Hattum AH; Schlüper HM; Hausheer FH; Pinedo HM; Boven E Int J Cancer; 2002 Jul; 100(1):22-9. PubMed ID: 12115582 [TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha potentiates the antiproliferative activity of CPT-11 against human colon cancer xenografts in nude mice. Kobayashi I; Ohwada S; Maemura M Anticancer Res; 1996; 16(5A):2677-80. PubMed ID: 8917369 [TBL] [Abstract][Full Text] [Related]
15. Novel cytotoxic 7-iminomethyl and 7-aminomethyl derivatives of camptothecin. Dallavalle S; Ferrari A; Merlini L; Penco S; Carenini N; De Cesare M; Perego P; Pratesi G; Zunino F Bioorg Med Chem Lett; 2001 Feb; 11(3):291-4. PubMed ID: 11212094 [TBL] [Abstract][Full Text] [Related]
16. Cellular resistance to camptothecins. Pommier Y; Gupta M; Valenti M; Nieves-Neira W Ann N Y Acad Sci; 1996 Dec; 803():60-73. PubMed ID: 8993501 [No Abstract] [Full Text] [Related]
17. Dependence of anticancer activity of camptothecins on maintaining their lactone function. Giovanella BC; Harris N; Mendoza J; Cao Z; Liehr J; Stehlin JS Ann N Y Acad Sci; 2000; 922():27-35. PubMed ID: 11193902 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activities and pharmacokinetics of silatecans DB-67 and DB-91. Yeh TK; Li CM; Chen CP; Chuu JJ; Huang CL; Wang HS; Shen CC; Lee TY; Chang CY; Chang CM; Chao YS; Lin CT; Chang JY; Chen CT Pharmacol Res; 2010 Feb; 61(2):108-15. PubMed ID: 19643180 [TBL] [Abstract][Full Text] [Related]
19. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice. Allegrini G; Goulette FA; Darnowski JW; Calabresi P Cancer Chemother Pharmacol; 2004 Mar; 53(3):261-6. PubMed ID: 14658007 [TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effects of CPT-11 on liver metastases in nude mice injected with human pancreatic tumor cells into their spleens]. Takeda S; Kono A Gan To Kagaku Ryoho; 1990 Dec; 17(12):2433-6. PubMed ID: 2260878 [No Abstract] [Full Text] [Related] [Next] [New Search]